Catalyst Biosciences

FibroGen Inc is a biopharmaceutical company based in South San Francisco, CA, specializing in the development of innovative therapies for serious and life-threatening diseases. With a focus on pancreatic cancer, prostate cancer, Duchenne muscular dystrophy, and anemia, the company is dedicated to bringing about positive changes in patients' lives through its pipeline of novel products. Driven by a commitment to responsible development, FibroGen Inc is actively engaged in clinical trials and collaborates with partners to accelerate the introduction of world-class innovations, particularly in China. With a growing team of dedicated professionals, the company strives to foster a culture of innovation and make a global impact in the field of biopharmaceuticals.Generated from the website

Imedd Inc is a technology company based in San Mateo, CA, specializing in software development for various industries. With a focus on innovation and efficiency, Imedd Inc provides tailored solutions to meet the unique needs of its clients. Generated from their business information

Sutro Biopharma, Inc. is a public biotechnology company based in South San Francisco, California, specializing in clinical stage drug discovery, development, and manufacturing. Utilizing its innovative XpressCF platform, the company focuses on creating protein therapeutics for cancer and autoimmune disorders, including cytokine-based immune-oncology therapeutics and bispecific antibodies. The company's product candidates, STRO-001 and STRO-002, are antibody-drug conjugates designed to target specific cancer markers such as CD74 and folate receptor-alpha, offering promising treatment options for patients with multiple myeloma, non-Hodgkin lymphoma, ovarian, and endometrial cancers. Generated from their website's infomation